Home » Newsletters » BioWorld Science

BioWorld Science

April 24, 2017

View Archived Issues

Rigel synthesizes fused imidazole and pyrazole derivatives as TGF-beta inhibitors

BeiGene initiates pivotal trial of BGB-A317 in China for classical Hodgkin's lymphoma

ReViral reports topline phase I data on RV-521 for RSV

Starpharma achieves preclinical milestone under AstraZeneca license agreement

FDA approves infliximab biosimilar Renflexis

Preliminary phase III data for sublingual treatment for Parkinson's disease 'off' episodes

Novartis presents phase IIa data for BPS-804

Roche studies RO-7020531 in phase I for chronic hepatitis B

EMA committee recommends approval of inotuzumab ozogamicin

PreveCeutical Medical and UniQuest sign research and option agreement

Atara and Merck & Co. in clinical trial collaboration to evaluate ATA-129 with pembrolizumab

Spinraza recommended for approval in E.U.

Phase III data presented for Hizentra for the treatment of myasthenia gravis

AbbVie conducting second phase III study of ABT-494 in psoriatic arthritis

EMA's CHMP recommends approval of Brineura for CLN2 disease

Wockhardt patents novel antibacterials

Sandoz rituximab and etanercept biosimilars recommended for approval in E.U.

EMA committee recommends E.U. approval of Kevzara

EMA committee adopts positive opinion on Opdivo in locally advanced or metastatic urothelial cancer

Reprogramming mouse astrocytes rescues aspects of motor behavior in a model of Parkinson's disease

Model of obesity and chronic liver disease allows study of effects on hepatic encephalopathy

FDA allows trials of inhaled BIO-11006 in adults with lung cancer

Janssen Holding publishes provisional notice of end result of Actelion tender offer

ND0612, a new formulation for subcutaneous infusion of levodopa/carbidopa in advanced PD

Tiziana obtains approval in Israel of phase II trial protocol for milciclib in refractory HCC

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Sept. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Sept. 22, 2025.
The ‘molecular revolution’ driving R&D of new cancer therapeutics
BioWorld Asia
“New explosions in biotechnology are allowing us to interrogate cancers at a very sophisticated level compared to before,” Dennis Slamon told audience members at...
CHMP recommends EU approval of Bayer’s Lynkuet for hot flashes
BioWorld
Following the first approvals in the U.K., Canada, Australia and Switzerland, the EMA’s Committee for Medicinal Products for Human Use (CHMP) is now recommending...
Remynd’s REM-127 yields positive phase II data in Alzheimer’s
BioWorld
Remynd NV has turned in positive phase IIa data for a new target in Alzheimer’s disease, showing that restoring calcium homeostasis in neurons reduces levels of...